Open access · CC-BY
via OpenAlex
Telomere length as a biomarker of aging and diseases
Azra Guzonjić, Miron Sopić, Barbara Ostanek, Jelena Kotur‐Stevuljević
Arhiv za farmaciju · 2022 · ▲ 4 citations
Abstract
As research related to healthspan(definition) and lifespan has become a hot topic, the necessity for a reliable and practical biomarker of aging (BoA), which can provide information about mortality and morbidity risk, along with remaining life expectancy, has increased. The chromosome terminus non-coding protective structure that prevents genomic instability is called a telomere(definition). The continual shortening of telomeres, which affects their structure as well as function, is a hallmark of agedness. The aforementioned process is a potential cause of age-related diseases (ARDs), leading to a bad prognosis and a low survival rate, which compromise health and longevity. Hence, studies scrutinizing the BoAs often include telomere length (TL) as a prospective candidate. The results of these studies suggest that TL measurement can only provide an approximate appraisal of the aging rate, and its implementation into clinical practice and routine use as a BoA has many limitations and challenges. Nevertheless, measuring TL while determining other biomarkers can be used to assess biological age. This review focuses on the importance of telomeres in health, senescence(definition), and diseases, as well as on summarizing the results and conclusions of previous studies evaluating TL as a potential BoA.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.5937/arhfarm72-36376
- Canonical
- link ↗
- Fetched
- 2026-10-12 MST
Cite this
APA
Guzonjić, A., Sopić, M., Ostanek, B., & Kotur‐Stevuljević, J. (2022). Telomere length as a biomarker of aging and diseases. <em>Arhiv za farmaciju</em>. https://doi.org/10.5937/arhfarm72-36376
Vancouver
Guzonjić A, Sopić M, Ostanek B, Kotur‐Stevuljević J. Telomere length as a biomarker of aging and diseases. Arhiv za farmaciju. 2022. doi:10.5937/arhfarm72-36376.
BibTeX
@article{azra2022Telome,
title = {Telomere length as a biomarker of aging and diseases},
author = {Azra Guzonjić and Miron Sopić and Barbara Ostanek and Jelena Kotur‐Stevuljević},
journal = {Arhiv za farmaciju},
year = {2022},
doi = {10.5937/arhfarm72-36376},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Signal Transduction and Targeted Therapy 2022
Open access · CC-BY
Nanoparticles in the diagnosis and treatment of vascular aging and related diseases
Ageing Research Reviews 2025
Citation only
Apheresis for senescence: Targeting the senescence-associated secretory phenotype to delay aging and age-related diseases
Probiotics and Antimicrobial Proteins 2025
Citation only
Gerobiotics: Exploring the Potential and Limitations of Repurposing Probiotics in Addressing Aging Hallmarks and Chronic Diseases
Physiology International 2018
Open access · OA
Advances and challenges in geroscience research: An update
Frontiers in Genetics 2021
Open access · CC-BY
Ranking Biomarkers of Aging by Citation Profiling and Effort Scoring
Aging and Disease 2023
Open access · CC-BY